TP53 and pancreatic ductal adenocarcinoma: Additionally, it has been shown that APC haploinsufficiency coupled with P53 deletion and KRASG12D activation can lead to the development of pancreatic intraepithelial neoplasia lesions in mice models with further progression to pancreatic ductal adenocarcinoma, demonstrating the importance of understanding variations in APC [57].